These data indicate that the mRNA levels of SE‐associated genes are particularly vulnerable to CDK12 inhibition, which prompted us to put forward the hypothesis that blocking SEs through targeting CDK12 may diminish the relevant cellular traits (e.g., proliferation, survival and stemness), thereby eventually alleviating liver metastasis in CRC. This evidence concerns the gene CDK12 and colorectal carcinoma.